However, patients with higher staining intensity for JAM2, HGF, and LIFR had significantly higher survival cycles than those with lower staining intensity for lung adenocarcinoma (Figures 9B, D, E), but for SPN, there was no significant correlation between their staining intensity and patients’ survival cycles (Figure 9C). The gene discussed is JAM2; the disease is lung adenocarcinoma.